JETEMA Co.,Ltd. Logo

JETEMA Co.,Ltd.

Develops and manufactures toxins, fillers, and threads for the aesthetic medicine market.

216080 | KO

Overview

Corporate Details

ISIN(s):
KR7216080002
LEI:
Country:
South Korea
Address:
강원도 원주시 지정면 조엄로 321, 원주시

Description

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.5 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-04 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.8 KB
2025-06-27 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-06-25 00:00
주요사항보고서(전환사채권발행결정)
Korean 70.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-09 00:00
금전대여결정
Korean 19.3 KB
2025-04-30 00:00
소속부변경
Korean 3.6 KB
2025-04-28 00:00
기타경영사항(자율공시)
Korean 7.6 KB
2025-04-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.1 KB
2025-04-15 00:00
주식등의대량보유상황보고서(일반)
Korean 174.7 KB
2025-04-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-04-11 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all JETEMA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JETEMA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JETEMA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.